“…Some bioactive molecules containing quinoxalin-2(1 H )-one skeleton, such as Compounds 1 - 3 , also show potential applications in medicinal chemistry fields (Meyer et al, 2006 ; Khattab et al, 2015 ; Qin et al, 2015 ) ( Figure 1A ). Because of their synthetic usefulness and potential biological importance, the introduction of functional groups into the C3-position of the quinoxalin-2(1 H )-ones has already become a research hotspot, and various protocols for the direct C3-H functionalization of quinoxalin-2(1 H )-ones have been reported (Ebersol et al, 2019 ; Gu et al, 2019 ; Hong et al, 2019 ; Li et al, 2019 ; Peng et al, 2019 ; Rostoll-Berenguer et al, 2019 ; Teng et al, 2019 ; Wang et al, 2019a , 2020 ; Xie et al, 2019b ; Zhao et al, 2019 ; Zheng and Studer, 2019 ; Tian et al, 2020 ; Yuan et al, 2020 ). In particular, the C3-H functionalization of quinoxalin-2(1 H )-ones involving hypervalent iodine reagents has drawn wide attention for the aforementioned advantages of hypervalent iodine reagents, mainly including arylation (Paul et al, 2017 ; Yin and Zhang, 2017 ), trifluoromethylation (Wang et al, 2018 ; Xue et al, 2019a ), alkylation (Wang et al, 2019b ; Xie et al, 2019a ; Xue et al, 2019b ; Shen et al, 2020 ), and alkoxylation (Xu et al, 2019 ; Yang et al, 2019 ) of quinoxalin-2(1 H )-ones, which provide convenient and environmentally friendly means for the synthesis of 3-substituted quinoxalinone derivatives.…”